Yardena Samuels and colleagues identified somatic mutations in 29 melanoma samples and found an interesting synonymous mutation in the Bcl-2-like protein 12 (BCL2L12) gene that is as an anti-apoptotic factor (a C to T change at position 51 (F17F)) [8]. This evidence concerns the gene BCL2L12 and melanoma.